Lisata Therapeutics raises CEO salary to $717,229, CMO salary to $599,342 in amended employment agreements

LISATA THERAPEUTICS, INC.

CEO David Mazzo base salary increased to $717,229 from $633,032; $12,000 non-accountable expense allowance removed.
CMO Kristen Buck base salary increased to $599,342 from $550,000.
Amended severance terms for CEO, CMO, CAO Nisco, and GC Imam; includes COBRA reimbursement changes and Section 409A clarifications.
Change in Control definition amended to include shareholder-approved complete liquidation, subject to 409A requirements.

item 5.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.